Cita APA

Coghill, A. E., Bu, W., Nguyen, H., Hsu, W., Yu, K. J., Lou, P., . . . Cohen, J. I. (2016). High levels of antibody that neutralize B-cell infection of Epstein-Barr virus and that bind EBV gp350 are associated with a lower risk of nasopharyngeal carcinoma. Clin Cancer Res.

Chicago Style Citation

Coghill, Anna E., et al. "High Levels of Antibody That Neutralize B-cell Infection of Epstein-Barr Virus and That Bind EBV Gp350 Are Associated With a Lower Risk of Nasopharyngeal Carcinoma." Clin Cancer Res 2016.

Cita MLA

Coghill, Anna E., et al. "High Levels of Antibody That Neutralize B-cell Infection of Epstein-Barr Virus and That Bind EBV Gp350 Are Associated With a Lower Risk of Nasopharyngeal Carcinoma." Clin Cancer Res 2016.